← Eichor
Condition: Huntington Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Huntington Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers
Phase 2 · 5 location(s) · Western Sydney Local Health District · NCT05509153Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06147414FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Phase N/A · 1 location(s) · xCures · NCT06539169Home-based TDCS (Transcranial Direct Current Stimulation) for Cognitive and Behavioral Symptoms in Huntington's Disease
NA · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT06843252University of Central Florida CereBank
Phase N/A · 1 location(s) · University of Central Florida · NCT06876857Social Cognition Training in Individuals With Huntington's Disease
NA · 1 location(s) · Rush University Medical Center · NCT06828471Cognitive Assessment Tools for Huntington's Disease.
Phase N/A · 1 location(s) · Ohio State University · NCT06546488Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Phase N/A · 183 location(s) · CHDI Foundation, Inc. · NCT01574053Gene Therapy Development and Validation for Huntington's Disease Fibro TG-HD
NA · 1 location(s) · University Hospital, Angers · NCT06444217Huntington's Disease Biobank: Advancing Remote Monitoring and Deep Phenotyping
Phase N/A · 1 location(s) · Stanford University · NCT06941662Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease
Phase 1/Phase 2 · 1 location(s) · Leslie Thompson · NCT07451613Evaluation of Three Tests to Assess Social Cognition in Huntington Disease
Phase N/A · 1 location(s) · Region Skane · NCT07253038Retinal Imaging in Neurodegenerative Disease
Phase N/A · 1 location(s) · Duke University · NCT03233646A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease
Phase 1 · 2 location(s) · Sarepta Therapeutics, Inc. · NCT07536061A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease
Phase 1 · 6 location(s) · Hoffmann-La Roche · NCT07246941Study to Evaluate Music Therapy on Irritability and Impulsivity in Patients With Huntington's Disease (MUSIC-HD)
NA · 1 location(s) · Poitiers University Hospital · NCT06414967Innovative Imaging and Cognitive BIOmarkers to Predict Huntington's Disease Progression
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05808153HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's
Phase N/A · 40 location(s) · University College, London · NCT02855476A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease
Phase 1 · 19 location(s) · Alnylam Pharmaceuticals · NCT06585449iMagemHTT-009- FIH Evaluation of Novel Mutant Huntingtin PET Radioligand [11C]CHDI-00491009
EARLY_Phase 1 · 1 location(s) · CHDI Foundation, Inc. · NCT06634628IMarkHD: in Vivo Longitudinal Imaging of HD Pathology
Phase N/A · 1 location(s) · King's College London · NCT03434548Home-based Transcranial Direct Current Stimulation Open Trial for Behavioral and Cognitive Symptoms in Huntington's Dise
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT05326451A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
Phase 1/Phase 2 · 5 location(s) · Hoffmann-La Roche · NCT06826612Study of BDNF Pathway Biomarkers in the Cerebrospinal Fluid in Patients With Huntington's Disease
NA · 1 location(s) · University Hospital, Montpellier · NCT04012411Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05360082Hinting Task for Huntington's Disease
Phase N/A · 1 location(s) · University Medical Center Groningen · NCT06774443Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases
Phase N/A · 1 location(s) · Hadassah Medical Organization · NCT00874783Longitudinal Endpoint Assessment of Disease Burden in HD
Phase N/A · 1 location(s) · Huntington Study Group · NCT06475898Trial of the Combined Use of Thiamine and Biotin in Patients With Huntington's Disease
Phase 2 · 3 location(s) · Fundación Pública Andaluza para la gestión de la Investigaci · NCT04478734A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Phase 3 · 41 location(s) · Novartis Pharmaceuticals · NCT07326709
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.